Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 study evaluating oral minoxidil to treat hair loss in cancer survivors; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • minoxidil (oral) (minoxidil)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Survivors of Childhood Cancer, Alopecia | Phase 2 | Status: ACTIVE_NOT_RECRUITING